NCT01619865 Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01601535 Study of MLN8237 in Combination With Irinotecan and Temozolomide Status COMPLETED Phase PHASE1/PHASE2
NCT01598454 Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides Status COMPLETED Phase PHASE1
NCT01592045 ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT01589341 Studying Chromosomes in Samples From Younger Patients With Neuroblastoma Status COMPLETED Phase N/A
NCT01583842 124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study Status TERMINATED Phase EARLY_PHASE1
NCT01576692 Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma Status COMPLETED Phase PHASE1
NCT01553448 Studying Gene Expression in Samples From Younger Patients With Neuroblastoma Status COMPLETED Phase N/A
NCT01526603 High Dose Chemotherapy and Autologous Transplant for Neuroblastoma Status COMPLETED Phase NA
NCT01525251 Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty Status UNKNOWN Phase N/A
NCT01520233 Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma Status COMPLETED Phase N/A
NCT01518413 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01510600 Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma Status COMPLETED Phase N/A
NCT01505608 Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT01493830 Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma Status COMPLETED Phase N/A
NCT01492673 Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Status COMPLETED Phase PHASE2
NCT01483820 Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT01482741 Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging Status COMPLETED Phase N/A